Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

399 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
Jacobson IM, Dore GJ, Foster GR, Fried MW, Radu M, Rafalsky VV, Moroz L, Craxi A, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Scott J, Sinha R, Beumont-Mauviel M. Jacobson IM, et al. Among authors: Dore GJ. Lancet. 2014 Aug 2;384(9941):403-13. doi: 10.1016/S0140-6736(14)60494-3. Epub 2014 Jun 4. Lancet. 2014. PMID: 24907225 Clinical Trial.
HIV-1 infection among female commercial sex workers in rural Thailand.
Gray JA, Dore GJ, Li Y, Supawitkul S, Effler P, Kaldor JM. Gray JA, et al. Among authors: Dore GJ. AIDS. 1997 Jan;11(1):89-94. doi: 10.1097/00002030-199701000-00013. AIDS. 1997. PMID: 9110080
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Freeman AJ, et al. Among authors: Dore GJ. Hepatology. 2001 Oct;34(4 Pt 1):809-16. doi: 10.1053/jhep.2001.27831. Hepatology. 2001. PMID: 11584380
Immunity against hepatitis C virus infection.
Dore GJ, Freeman AJ, Kaldor JM. Dore GJ, et al. Lancet. 2002 Sep 28;360(9338):1019-20; author reply 1020-1. doi: 10.1016/S0140-6736(02)11102-0. Lancet. 2002. PMID: 12383685 No abstract available.
Epidemiology of hepatitis C virus infection in Australia.
Dore GJ, Law M, MacDonald M, Kaldor JM. Dore GJ, et al. J Clin Virol. 2003 Feb;26(2):171-84. doi: 10.1016/s1386-6532(02)00116-6. J Clin Virol. 2003. PMID: 12600649 Review.
399 results
Jump to page